Second doctor named in FIR, counter-complaint filed
December 30, 2025
- New Study Looks At Shopping Malls And What They Mean To People
- Mereo BioPharma Reports P-III (ORBIT & COSMIC) Trials Findings on Setrusumab in Osteogenesis Imperfecta
- ARS Pharmaceuticals Reports NMPA Approval of neffy 2mg (Epinephrine Nasal Spray) to Treat Type I Allergic Reactions
- Lupin signs exclusive agreement with Gan & Lee for Bofanglutide in India
Headlines
